Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medibank PvtASX:MPL -0.59%79 Debt-to-Equity is 0.12 as of Dec. 2025, which is 33% above its 10-year median of 0.09. GuruFocus rates ASX:MPL with a GF Score™ of 79/100 and a GF Value™ of A$4.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 407 Insurance companies, Medibank Pvt ranks better than 64.37% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Medibank Pvt's Debt-to-Equity or its related term are showing as below:
ASX:MPL'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.09 Max: 0.12
Current: 0.12
During the past 11 years, the highest Debt-to-Equity Ratio of Medibank Pvt was 0.12. The lowest was 0.04. And the median was 0.09.
ASX:MPL's Debt-to-Equity is ranked better than 64.37% of 407
companies
in the Insurance industry
Industry Median: 0.2
vs ASX:MPL: 0.12
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Medibank Pvt Debt-to-Equity Related Terms
Medibank Pvt Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Medibank Pvt's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:MPL vs FNF, AXS, FAF: Debt-to-Equity Comparison
For the Insurance - Specialty subindustry, Medibank Pvt's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt Debt-to-Equity vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (ASX:MPL) has a Debt-to-Equity of 0.12 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medibank Pvt and its competitors. This is 33% above median its historical median of 0.09. Over the past decade, Medibank Pvt's Debt-to-Equity has ranged from 0.04 to 0.12. According to the industry distribution chart, Medibank Pvt ranks #145 out of 407 companies in the Insurance industry, placing it in the top 35.6%.
Is Medibank Pvt's Debt-to-Equity too high?
Medibank Pvt's current Debt-to-Equity of 0.12 is 33% above median its 10-year median of 0.09. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.12. The Insurance industry median Debt-to-Equity is 0.20. Medibank Pvt's value of 0.12 is 40% below this industry median. Based on the distribution chart, Medibank Pvt ranks #145 out of 407 companies in the Insurance industry, which is above the industry midpoint. Overall, Medibank Pvt has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's Debt-to-Equity compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #145 out of 407 companies for Debt-to-Equity. This puts Medibank Pvt in the upper half of its industry. The industry median Debt-to-Equity is 0.20. Medibank Pvt's value of 0.12 is 40% below this benchmark. Historically, Medibank Pvt's own Debt-to-Equity has ranged from 0.04 to 0.12 over the past decade. While the company's 10-year median is 0.09 vs. the industry median of 0.20, Medibank Pvt has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Insurance company?
The median Debt-to-Equity among Insurance companies is 0.20, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current Debt-to-Equity of 0.12 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medibank Pvt and its competitors. For the Insurance industry, the median Debt-to-Equity is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current Debt-to-Equity is 0.12, which is 33% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.40, compared to a current price of A$5.05 — trading 14.8% above its estimated fair value. The current Debt-to-Equity is 0.12, which is 33% above median its 10-year median of 0.09 and 40% below the Insurance industry median of 0.20. Medibank Pvt's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current Debt-to-Equity is 0.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.05 is trading 14.8% above its estimated GF Value™ of A$4.40.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
Debt-to-Equity: 0.12 (33% above median its 10-year median of 0.09)
GF Value™: A$4.40 vs. price of A$5.05 (14.8% above fair value)
Industry Position: 40% below the Insurance median (#145 of 407)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
79GF Score
Get the complete analysis for ASX:MPL
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
